Oncology Institute (DFPH) Depreciation & Amortization (CF) (2021 - 2026)

Oncology Institute (DFPH) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 9.42% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $6.8 million (up 2.95% YoY), and the FY2025 full-year result was $6.9 million, up 10.45% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $1.6 million, down from $1.6 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $1.8 million in Q2 2025 and bottomed at $987000.0 in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $1.6 million (2024), against an average of $1.5 million.
• The widest annual swing landed in 2023, when Depreciation & Amortization (CF) soared 49.74%; it then fell 9.42% in 2026.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.2 million in 2022, then surged by 32.3% to $1.6 million in 2023, then increased by 8.24% to $1.7 million in 2024, then fell by 4.39% to $1.6 million in 2025, then retreated by 0.98% to $1.6 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.

Peer Comparison